• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒1型合并感染患者中丙型肝炎病毒准种的基因变异趋势

Trends for genetic variation of Hepatitis C Virus quasispecies in Human Immunodeficiency virus-1 coinfected patients.

作者信息

López-Labrador F Xavier, Dove Lorna, Hui Chee-Kin, Phung Yume, Kim Michael, Berenguer Marina, Wright Teresa L

机构信息

Public Health Department, Generalitat Valenciana and Evolutionary Genetics Unit, Institut Cavanilles de Biodiversitat i Biologia Evolutiva, University of Valencia, Apt. Of. 2085, E-46071 Valencia, Spain.

出版信息

Virus Res. 2007 Dec;130(1-2):285-91. doi: 10.1016/j.virusres.2007.05.016. Epub 2007 Jun 29.

DOI:10.1016/j.virusres.2007.05.016
PMID:17601623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2919681/
Abstract

Chronic infection by Hepatitis C Virus (HCV) causes liver fibrosis, which is accelerated by unknown mechanisms in patients with HIV-1 coinfection. The evolution of HCV quasispecies in this setting of coinfection is not fully understood. To compare HCV quasispecies between HIV-HCV coinfection and HCV monoinfection, we sequenced 340 HCV clones from the HVR-1 and NS3 regions at two different time points in two groups of treatment-naïve patients with HCV-1a infection: (1) HIV-HCV positive (n=6); and (2) HIV negative-HCV positive (n=3). In HCV/HIV coinfection, we found a trend for reduced HCV genetic complexity and diversity, and a trend towards reduced dN/dS ratios in the HVR-1 region, especially in those patients with CD4<200cells/mm(3), who lost positive selective immune pressure in the HVR-1 region. Differences in immune regulation of HCV quasispecies in HIV coinfected individuals deserve further exploration to clarify the different outcomes of chronic hepatitis C noted between the immunocompromised and the immunocompetent host.

摘要

丙型肝炎病毒(HCV)的慢性感染会导致肝纤维化,在合并感染HIV-1的患者中,肝纤维化会通过未知机制加速发展。在这种合并感染情况下,HCV准种的演变尚未完全明确。为了比较HIV-HCV合并感染与HCV单一感染之间的HCV准种,我们在两组未经治疗的HCV-1a感染患者的两个不同时间点,对来自高变区1(HVR-1)和NS3区域的340个HCV克隆进行了测序:(1)HIV-HCV阳性(n = 6);(2)HIV阴性-HCV阳性(n = 3)。在HCV/HIV合并感染中,我们发现HCV基因复杂性和多样性有降低的趋势,并且在HVR-1区域dN/dS比值有降低的趋势,尤其是在那些CD4<200细胞/mm³的患者中,他们在HVR-1区域失去了阳性选择免疫压力。对于HIV合并感染个体中HCV准种免疫调节的差异,值得进一步探索,以阐明免疫受损宿主和免疫健全宿主之间慢性丙型肝炎的不同结局。

相似文献

1
Trends for genetic variation of Hepatitis C Virus quasispecies in Human Immunodeficiency virus-1 coinfected patients.人类免疫缺陷病毒1型合并感染患者中丙型肝炎病毒准种的基因变异趋势
Virus Res. 2007 Dec;130(1-2):285-91. doi: 10.1016/j.virusres.2007.05.016. Epub 2007 Jun 29.
2
Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.丙型肝炎病毒 NS3/4A 准种多样性在 HIV-1 合并感染患者急性丙型肝炎感染中的研究。
J Viral Hepat. 2014 Jun;21(6):e19-28. doi: 10.1111/jvh.12254. Epub 2014 Mar 27.
3
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.根据高效抗逆转录病毒疗法的反应模式,HIV/HCV合并感染患者接受1年治疗后HVR-1准种的演变情况。
Antivir Ther. 2006;11(1):87-94.
4
Impact of highly active antiretroviral therapy on hepatitis C virus protease quasispecies diversity in HIV co-infected patients.高效抗逆转录病毒疗法对 HIV 合并感染患者丙型肝炎病毒蛋白酶准种多样性的影响。
J Med Virol. 2010 May;82(5):791-8. doi: 10.1002/jmv.21679.
5
Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy.开始接受高效抗逆转录病毒治疗的HIV-HCV合并感染患者中的丙型肝炎病毒(HCV)多样性
J Infect Dis. 2004 Apr 15;189(8):1472-81. doi: 10.1086/382959. Epub 2004 Mar 29.
6
Impact of interferon-ribavirin treatment on hepatitis C virus (HCV) protease quasispecies diversity in HIV- and HCV-coinfected patients.聚乙二醇干扰素联合利巴韦林治疗对 HIV/HCV 共感染患者丙型肝炎病毒(HCV)蛋白酶准种多样性的影响。
J Infect Dis. 2010 Sep 15;202(6):889-93. doi: 10.1086/655784.
7
Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection.慢性丙型肝炎病毒感染患者接受聚乙二醇干扰素治疗期间,E1/E2区域内的准种异质性作为预处理变量。
J Virol. 2005 Mar;79(5):3071-83. doi: 10.1128/JVI.79.5.3071-3083.2005.
8
CD4+ T-cell recovery with suppressive ART-induced rapid sequence evolution in hepatitis C virus envelope but not NS3.在接受抑制性抗逆转录病毒治疗(ART)时,CD4 + T细胞恢复导致丙型肝炎病毒包膜蛋白而非NS3蛋白发生快速序列进化。
AIDS. 2016 Mar 13;30(5):691-700. doi: 10.1097/QAD.0000000000000997.
9
Previous failure of interferon-based therapy does not alter the frequency of HCV NS3 protease or NS5B polymerase inhibitor resistance-associated variants: longitudinal analysis in HCV/HIV co-infected patients.既往干扰素治疗失败并不改变 HCV NS3 蛋白酶或 NS5B 聚合酶抑制剂耐药相关变异的频率:HCV/HIV 合并感染患者的纵向分析。
Int J Antimicrob Agents. 2015 Aug;46(2):219-24. doi: 10.1016/j.ijantimicag.2015.04.011. Epub 2015 Jun 4.
10
HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability.HIV感染与抗逆转录病毒疗法:对丙型肝炎病毒准种变异性的影响。
J Infect Dis. 2006 May 1;193(9):1211-8. doi: 10.1086/502974. Epub 2006 Mar 28.

引用本文的文献

1
Similarities between Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Genetic and Phenotypic Protease Quasispecies Diversity.1型人类免疫缺陷病毒与丙型肝炎病毒基因和表型蛋白酶准种多样性之间的相似性
J Virol. 2015 Oct;89(19):9758-64. doi: 10.1128/JVI.01097-15. Epub 2015 Jul 15.
2
Hepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfection.丙型肝炎病毒(HCV)/艾滋病病毒(HIV)合并感染中丙型肝炎病毒NS3序列多样性及抗病毒耐药相关变异频率
Antimicrob Agents Chemother. 2014 Oct;58(10):6079-92. doi: 10.1128/AAC.03466-14. Epub 2014 Aug 4.
3
Vertical transmission of hepatitis C virus: a tale of multiple outcomes.

本文引用的文献

1
HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability.HIV感染与抗逆转录病毒疗法:对丙型肝炎病毒准种变异性的影响。
J Infect Dis. 2006 May 1;193(9):1211-8. doi: 10.1086/502974. Epub 2006 Mar 28.
2
Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells.丙型肝炎病毒基因型在血浆和外周血单个核细胞之间的分隔
J Virol. 2005 May;79(10):6349-57. doi: 10.1128/JVI.79.10.6349-6357.2005.
3
HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV.
丙型肝炎病毒的垂直传播:多种结局的故事。
Infect Genet Evol. 2013 Dec;20:465-70. doi: 10.1016/j.meegid.2013.10.005. Epub 2013 Oct 18.
4
Substance abuse, HIV-1 and hepatitis.药物滥用、人类免疫缺陷病毒1型与肝炎
Curr HIV Res. 2012 Oct;10(7):557-71. doi: 10.2174/157016212803306023.
5
The natural history of early hepatitis C virus evolution; lessons from a global outbreak in human immunodeficiency virus-1-infected individuals.早期丙型肝炎病毒进化的自然史;人类免疫缺陷病毒-1 感染个体中全球暴发的教训。
J Gen Virol. 2011 Oct;92(Pt 10):2227-2236. doi: 10.1099/vir.0.033910-0. Epub 2011 Jul 20.
6
Temporal variations in the hepatitis C virus intrahost population during chronic infection.慢性感染期间丙型肝炎病毒宿主内种群的时间变化。
J Virol. 2011 Jul;85(13):6369-80. doi: 10.1128/JVI.02204-10. Epub 2011 Apr 27.
7
The hepatitis C virus 5'UTR genomic region remains highly conserved under HAART: a 4- to 8-year longitudinal study from HCV/HIV co-infected patients.丙型肝炎病毒5'非翻译区基因组区域在高效抗逆转录病毒治疗下仍高度保守:一项对丙型肝炎病毒/艾滋病病毒合并感染患者的4至8年纵向研究。
AIDS Res Hum Retroviruses. 2010 May;26(5):527-32. doi: 10.1089/aid.2009.0237.
8
Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.丙型肝炎病毒与人类免疫缺陷病毒合并感染:病毒学、免疫学及临床结局
J Virol. 2009 Aug;83(15):7366-74. doi: 10.1128/JVI.00191-09. Epub 2009 May 6.
丙型肝炎病毒准种进化:与感染丙型肝炎病毒或丙型肝炎病毒/人类免疫缺陷病毒的血友病患者进展至终末期肝病的关联
Blood. 2005 Jan 15;105(2):533-41. doi: 10.1182/blood-2004-04-1452. Epub 2004 Sep 16.
4
Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy.开始接受高效抗逆转录病毒治疗的HIV-HCV合并感染患者中的丙型肝炎病毒(HCV)多样性
J Infect Dis. 2004 Apr 15;189(8):1472-81. doi: 10.1086/382959. Epub 2004 Mar 29.
5
Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes.丙型肝炎病毒变体在循环B细胞和单核细胞中频繁出现区室化现象。
Hepatology. 2004 Mar;39(3):817-25. doi: 10.1002/hep.20087.
6
Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.慢性丙型肝炎患者丙型肝炎病毒非结构蛋白3的基因变异性及病毒特异性CD8 +反应
J Med Virol. 2004 Apr;72(4):575-85. doi: 10.1002/jmv.20036.
7
Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients.高效抗逆转录病毒疗法和免疫状态对人类免疫缺陷病毒/丙型肝炎病毒合并感染患者丙型肝炎病毒准种多样性的影响。
J Virol. 2003 Feb;77(3):1940-50. doi: 10.1128/jvi.77.3.1940-1950.2003.
8
Hepatitis C and human immunodeficiency virus infection.丙型肝炎与人类免疫缺陷病毒感染
Hepatology. 2002 Nov;36(5 Suppl 1):S201-9. doi: 10.1053/jhep.2002.36380.
9
Influence of CD4 cell counts on the genetic heterogeneity of hepatitis C virus in patients coinfected with human immunodeficiency virus.
J Infect Dis. 2002 Mar 15;185(6):728-33. doi: 10.1086/339297. Epub 2002 Feb 28.
10
Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses.1型人类免疫缺陷病毒-丙型肝炎病毒合并感染:针对两种持续性病毒的细胞免疫反应的个体内比较
J Virol. 2002 Mar;76(6):2817-26. doi: 10.1128/jvi.76.6.2817-2826.2002.